Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration

Published:2022-06-27 Issue:5 Volume:11 Page:1705-1717
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Wykoff Charles C.^ORCID,Campochiaro Peter A.,Pieramici Dante J.,Khanani Arshad M.,Gune Shamika,Maia Mauricio,Kågedal Matts,Ding Han Ting,Maass Katie F.

Funder

Genentech

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s40123-022-00532-9.pdf

Reference28 articles.

1. Flaxel CJ, Adelman RA, Bailey ST, et al. Age-related macular degeneration Preferred Practice Pattern®. Ophthalmology. 2020;127:P1–65.

2. Ferrara N, Damico L, Shams N, Lowman H, Kim R. Development of ranibizumab, an anti–vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina. 2006;26:859–70.

3. Xu L, Lu T, Tuomi L, et al. Pharmacokinetics of ranibizumab in patients with neovascular age-related macular degeneration: a population approach. Invest Ophthalmol Vis Sci. 2013;54:1616–24.

4. Ritschel WA, Kearns GL. Handbook of Basic Pharmacokinetics… Including Clinical Applications. 7th ed. Washington, DC: American Pharmacists Association; 2009.

5. Brown DM, Kaiser PK, Michels M, et al. ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–44.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration: Where Do We Stand? Overview of Pharmacokinetics, Clinical Results, and Future Directions;Pharmaceutics;2024-02-23

2. Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results;Nature Medicine;2024-02

3. Clinical Trials and Future Outlooks of the Port Delivery System with Ranibizumab: A Narrative Review;Ophthalmology and Therapy;2023-12-06

4. Intravitreal injectable hydrogel rods with long-acting bevacizumab delivery to the retina;Acta Biomaterialia;2023-11

5. An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye;ACS Omega;2023-09-22